South Korean researchers have, for the first time in the world, uncovered how messenger ribonucleic acid (mRNA) vaccines ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...

NIH-supported researchers have developed a new method using a protein from tardigrades to help protect healthy tissue during ...

Mouse cells tweaked to produce the tardigrade protein incurred less DNA damage than unaltered cells — hinting at a new tool for cancer patient care.

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

Scientists would examine the DNA and RNA (RNA and mRNA serve different functions in a cell) of a specific patient's tumor to create a vaccine to teach that person's immune system to target and ...

In this interview, Technology Networks talked to Dr. Stacy Lindborg, president, chief executive officer and board member at IMUNON, Inc., who shares how its PlaCCine® platform could reshape vaccine ...

Sungyul Lee, PhD, principal scientist and lab leader at Bio R&D, Samsung Biologics Therapeutic mRNA manufacturing begins with in vitro transcription, in which plasmid DNA (or pDNA) is linearized ...

For years, scientists worldwide have been experimenting with messenger RNA (mRNA) vaccines, unable to secure the funding or ...